This research report focuses on the Self-administered Parenteral Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Study Coverage
- 1.1 Self-administered Parenteral Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Self-administered Parenteral Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
- 1.2.2 Pre-filled Syringes
- 1.2.3 Autoinjectors
- 1.2.4 Pen Injectors
- 1.2.5 Others
- 1.3 Market by Application
- 1.3.1 Global Self-administered Parenteral Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
- 1.3.2 Pharmacy
- 1.3.3 Online Sales
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Executive Summary
- 2.1 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
- 2.2 Global Self-administered Parenteral Revenue by Region
- 2.2.1 Global Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
- 2.2.2 Global Self-administered Parenteral Revenue by Region (2019-2024)
- 2.2.3 Global Self-administered Parenteral Revenue by Region (2025-2030)
- 2.2.4 Global Self-administered Parenteral Revenue Market Share by Region (2019-2030)
- 2.3 Global Self-administered Parenteral Sales Estimates and Forecasts 2019-2030
- 2.4 Global Self-administered Parenteral Sales by Region
- 2.4.1 Global Self-administered Parenteral Sales by Region: 2019 VS 2023 VS 2030
- 2.4.2 Global Self-administered Parenteral Sales by Region (2019-2024)
- 2.4.3 Global Self-administered Parenteral Sales by Region (2025-2030)
- 2.4.4 Global Self-administered Parenteral Sales Market Share by Region (2019-2030)
- 2.5 US & Canada
- 2.6 Europe
- 2.7 China
- 2.8 Asia (excluding China)
- 2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
- 3.1 Global Self-administered Parenteral Sales by Manufacturers
- 3.1.1 Global Self-administered Parenteral Sales by Manufacturers (2019-2024)
- 3.1.2 Global Self-administered Parenteral Sales Market Share by Manufacturers (2019-2024)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Self-administered Parenteral in 2023
- 3.2 Global Self-administered Parenteral Revenue by Manufacturers
- 3.2.1 Global Self-administered Parenteral Revenue by Manufacturers (2019-2024)
- 3.2.2 Global Self-administered Parenteral Revenue Market Share by Manufacturers (2019-2024)
- 3.2.3 Global Top 10 and Top 5 Companies by Self-administered Parenteral Revenue in 2023
- 3.3 Global Key Players of Self-administered Parenteral, Industry Ranking, 2022 VS 2023 VS 2024
- 3.4 Global Self-administered Parenteral Sales Price by Manufacturers
- 3.5 Analysis of Competitive Landscape
- 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.5.2 Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Key Manufacturers of Self-administered Parenteral, Manufacturing Base Distribution and Headquarters
- 3.7 Global Key Manufacturers of Self-administered Parenteral, Product Offered and Application
- 3.8 Global Key Manufacturers of Self-administered Parenteral, Date of Enter into This Industry
- 3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Self-administered Parenteral Sales by Type
- 4.1.1 Global Self-administered Parenteral Historical Sales by Type (2019-2024)
- 4.1.2 Global Self-administered Parenteral Forecasted Sales by Type (2025-2030)
- 4.1.3 Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
- 4.2 Global Self-administered Parenteral Revenue by Type
- 4.2.1 Global Self-administered Parenteral Historical Revenue by Type (2019-2024)
- 4.2.2 Global Self-administered Parenteral Forecasted Revenue by Type (2025-2030)
- 4.2.3 Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
- 4.3 Global Self-administered Parenteral Price by Type
- 4.3.1 Global Self-administered Parenteral Price by Type (2019-2024)
- 4.3.2 Global Self-administered Parenteral Price Forecast by Type (2025-2030)
5 Market Size by Application
- 5.1 Global Self-administered Parenteral Sales by Application
- 5.1.1 Global Self-administered Parenteral Historical Sales by Application (2019-2024)
- 5.1.2 Global Self-administered Parenteral Forecasted Sales by Application (2025-2030)
- 5.1.3 Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
- 5.2 Global Self-administered Parenteral Revenue by Application
- 5.2.1 Global Self-administered Parenteral Historical Revenue by Application (2019-2024)
- 5.2.2 Global Self-administered Parenteral Forecasted Revenue by Application (2025-2030)
- 5.2.3 Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
- 5.3 Global Self-administered Parenteral Price by Application
- 5.3.1 Global Self-administered Parenteral Price by Application (2019-2024)
- 5.3.2 Global Self-administered Parenteral Price Forecast by Application (2025-2030)
6 US & Canada
- 6.1 US & Canada Self-administered Parenteral Market Size by Type
- 6.1.1 US & Canada Self-administered Parenteral Sales by Type (2019-2030)
- 6.1.2 US & Canada Self-administered Parenteral Revenue by Type (2019-2030)
- 6.2 US & Canada Self-administered Parenteral Market Size by Application
- 6.2.1 US & Canada Self-administered Parenteral Sales by Application (2019-2030)
- 6.2.2 US & Canada Self-administered Parenteral Revenue by Application (2019-2030)
- 6.3 US & Canada Self-administered Parenteral Market Size by Country
- 6.3.1 US & Canada Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
- 6.3.2 US & Canada Self-administered Parenteral Sales by Country (2019-2030)
- 6.3.3 US & Canada Self-administered Parenteral Revenue by Country (2019-2030)
- 6.3.4 US
- 6.3.5 Canada
7 Europe
- 7.1 Europe Self-administered Parenteral Market Size by Type
- 7.1.1 Europe Self-administered Parenteral Sales by Type (2019-2030)
- 7.1.2 Europe Self-administered Parenteral Revenue by Type (2019-2030)
- 7.2 Europe Self-administered Parenteral Market Size by Application
- 7.2.1 Europe Self-administered Parenteral Sales by Application (2019-2030)
- 7.2.2 Europe Self-administered Parenteral Revenue by Application (2019-2030)
- 7.3 Europe Self-administered Parenteral Market Size by Country
- 7.3.1 Europe Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
- 7.3.2 Europe Self-administered Parenteral Sales by Country (2019-2030)
- 7.3.3 Europe Self-administered Parenteral Revenue by Country (2019-2030)
- 7.3.4 Germany
- 7.3.5 France
- 7.3.6 U.K.
- 7.3.7 Italy
- 7.3.8 Netherlands
8 China
- 8.1 China Self-administered Parenteral Market Size
- 8.1.1 China Self-administered Parenteral Sales (2019-2030)
- 8.1.2 China Self-administered Parenteral Revenue (2019-2030)
- 8.2 China Self-administered Parenteral Market Size by Application
- 8.2.1 China Self-administered Parenteral Sales by Application (2019-2030)
- 8.2.2 China Self-administered Parenteral Revenue by Application (2019-2030)
9 Asia (excluding China)
- 9.1 Asia Self-administered Parenteral Market Size by Type
- 9.1.1 Asia Self-administered Parenteral Sales by Type (2019-2030)
- 9.1.2 Asia Self-administered Parenteral Revenue by Type (2019-2030)
- 9.2 Asia Self-administered Parenteral Market Size by Application
- 9.2.1 Asia Self-administered Parenteral Sales by Application (2019-2030)
- 9.2.2 Asia Self-administered Parenteral Revenue by Application (2019-2030)
- 9.3 Asia Self-administered Parenteral Sales by Region
- 9.3.1 Asia Self-administered Parenteral Revenue by Region: 2019 VS 2023 VS 2030
- 9.3.2 Asia Self-administered Parenteral Revenue by Region (2019-2030)
- 9.3.3 Asia Self-administered Parenteral Sales by Region (2019-2030)
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 China Taiwan
- 9.3.7 Southeast Asia
- 9.3.8 India
10 Middle East, Africa and Latin America
- 10.1 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Type
- 10.1.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Type (2019-2030)
- 10.1.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Type (2019-2030)
- 10.2 Middle East, Africa and Latin America Self-administered Parenteral Market Size by Application
- 10.2.1 Middle East, Africa and Latin America Self-administered Parenteral Sales by Application (2019-2030)
- 10.2.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Application (2019-2030)
- 10.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country
- 10.3.1 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country: 2019 VS 2023 VS 2030
- 10.3.2 Middle East, Africa and Latin America Self-administered Parenteral Revenue by Country (2019-2030)
- 10.3.3 Middle East, Africa and Latin America Self-administered Parenteral Sales by Country (2019-2030)
- 10.3.4 Brazil
- 10.3.5 Mexico
- 10.3.6 Turkey
- 10.3.7 Israel
- 10.3.8 GCC Countries
11 Company Profiles
- 11.1 Becton, Dickinson and Company
- 11.1.1 Becton, Dickinson and Company Company Information
- 11.1.2 Becton, Dickinson and Company Overview
- 11.1.3 Becton, Dickinson and Company Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.1.4 Becton, Dickinson and Company Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Becton, Dickinson and Company Recent Developments
- 11.2 scPharmaceuticals
- 11.2.1 scPharmaceuticals Company Information
- 11.2.2 scPharmaceuticals Overview
- 11.2.3 scPharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.2.4 scPharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 scPharmaceuticals Recent Developments
- 11.3 Harro Hofliger
- 11.3.1 Harro Hofliger Company Information
- 11.3.2 Harro Hofliger Overview
- 11.3.3 Harro Hofliger Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.3.4 Harro Hofliger Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Harro Hofliger Recent Developments
- 11.4 Owen Mumford
- 11.4.1 Owen Mumford Company Information
- 11.4.2 Owen Mumford Overview
- 11.4.3 Owen Mumford Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.4.4 Owen Mumford Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Owen Mumford Recent Developments
- 11.5 Haselmeier
- 11.5.1 Haselmeier Company Information
- 11.5.2 Haselmeier Overview
- 11.5.3 Haselmeier Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.5.4 Haselmeier Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Haselmeier Recent Developments
- 11.6 Stevanato Group
- 11.6.1 Stevanato Group Company Information
- 11.6.2 Stevanato Group Overview
- 11.6.3 Stevanato Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.6.4 Stevanato Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Stevanato Group Recent Developments
- 11.7 Ypsomed AG
- 11.7.1 Ypsomed AG Company Information
- 11.7.2 Ypsomed AG Overview
- 11.7.3 Ypsomed AG Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.7.4 Ypsomed AG Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 Ypsomed AG Recent Developments
- 11.8 Solteam Group
- 11.8.1 Solteam Group Company Information
- 11.8.2 Solteam Group Overview
- 11.8.3 Solteam Group Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.8.4 Solteam Group Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Solteam Group Recent Developments
- 11.9 AstraZeneca
- 11.9.1 AstraZeneca Company Information
- 11.9.2 AstraZeneca Overview
- 11.9.3 AstraZeneca Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.9.4 AstraZeneca Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 AstraZeneca Recent Developments
- 11.10 Enable lnjections
- 11.10.1 Enable lnjections Company Information
- 11.10.2 Enable lnjections Overview
- 11.10.3 Enable lnjections Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.10.4 Enable lnjections Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Enable lnjections Recent Developments
- 11.11 CCBio
- 11.11.1 CCBio Company Information
- 11.11.2 CCBio Overview
- 11.11.3 CCBio Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.11.4 CCBio Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.11.5 CCBio Recent Developments
- 11.12 Phillips-Medisize Corporation
- 11.12.1 Phillips-Medisize Corporation Company Information
- 11.12.2 Phillips-Medisize Corporation Overview
- 11.12.3 Phillips-Medisize Corporation Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.12.4 Phillips-Medisize Corporation Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.12.5 Phillips-Medisize Corporation Recent Developments
- 11.13 Sorrel Medical
- 11.13.1 Sorrel Medical Company Information
- 11.13.2 Sorrel Medical Overview
- 11.13.3 Sorrel Medical Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.13.4 Sorrel Medical Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.13.5 Sorrel Medical Recent Developments
- 11.14 Krontec Healthcare
- 11.14.1 Krontec Healthcare Company Information
- 11.14.2 Krontec Healthcare Overview
- 11.14.3 Krontec Healthcare Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.14.4 Krontec Healthcare Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.14.5 Krontec Healthcare Recent Developments
- 11.15 Subcuject Aps
- 11.15.1 Subcuject Aps Company Information
- 11.15.2 Subcuject Aps Overview
- 11.15.3 Subcuject Aps Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.15.4 Subcuject Aps Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.15.5 Subcuject Aps Recent Developments
- 11.16 Ascendia Pharmaceuticals
- 11.16.1 Ascendia Pharmaceuticals Company Information
- 11.16.2 Ascendia Pharmaceuticals Overview
- 11.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.16.5 Ascendia Pharmaceuticals Recent Developments
- 11.17 West Pharmaceutical Services, Inc.
- 11.17.1 West Pharmaceutical Services, Inc. Company Information
- 11.17.2 West Pharmaceutical Services, Inc. Overview
- 11.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales, Price, Revenue and Gross Margin (2019-2024)
- 11.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Product Model Numbers, Pictures, Descriptions and Specifications
- 11.17.5 West Pharmaceutical Services, Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Self-administered Parenteral Industry Chain Analysis
- 12.2 Self-administered Parenteral Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Self-administered Parenteral Production Mode & Process
- 12.4 Self-administered Parenteral Sales and Marketing
- 12.4.1 Self-administered Parenteral Sales Channels
- 12.4.2 Self-administered Parenteral Distributors
- 12.5 Self-administered Parenteral Customers
13 Market Dynamics
- 13.1 Self-administered Parenteral Industry Trends
- 13.2 Self-administered Parenteral Market Drivers
- 13.3 Self-administered Parenteral Market Challenges
- 13.4 Self-administered Parenteral Market Restraints
14 Key Findings in The Global Self-administered Parenteral Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer